Silver nanoparticles as a sensing agent to compare non-diabetic blood depends on absorbance for glucose sensing.

The aim of this study was to evaluate the size and uptake of chemically synthesized silver nanoparticles in the blood of non-diabetic patients by optically and morphologically characterizing the nucleation and growth processes. Materials and methods: For the analysis of diabetic blood, chemically synthesized silver nanoparticles were used with silver nitrate, sodium borohydride (NaBH4), and sodium citrate as capping agents. A total of seven sets of 26 samples were tested with a G performance of 80% and a 95% confidence interval. Nanoparticles were examined using UV-Vis spectroscopy as well as scanning and electron microscopy (SEM). Results: Check the absorbance and morphology of the sample. Nanoparticles absorb different wavelengths to different degrees. The uptake of nanoparticles needs to be studied. Study particles in the 200–700 nm range. It shows significant absorption in the UV part of the visible spectrum in the 200–400 nm range. SEM topographical examination confirmed the size distribution. The size distribution of the particles was examined using a scanning electron microscope (SEM). At a concentration of 70 mM, the absorbance of diabetic blood was statistically significant at 0.227 (p>0.05). Conclusions: The nucleation and growth process was used to produce silver nanoparticles for diabetes analysis. Silver nanoparticles were prepared using sodium citrate as a capping agent. Although less toxic, it lacks antimicrobial properties. Therefore, silver nanoparticles should be synthesized for in vivo testing. Nanoparticles can be used in surface coating process. [ABSTRACT FROM AUTHOR]